[1]
|
Rigel, D.S. and Carucci, J.A. (2000) Malignant Melanoma: Prevention, Early Detection, and Treatment in the 21st Century. CA: A Cancer Journal for Clinicians, 50, 215-236. http://dx.doi.org/10.3322/canjclin.50.4.215
|
[2]
|
Friedman, R.J., Rigel, D.S., Silverman, M.K., et al. (1991) Malignant Melanoma in the 1990s: The Continued Importance of Early Detection and the Role of Physician Examination and Self-Examination of the Skin. CA: A Cancer Journal for Clinicians, 41, 201-226. http://dx.doi.org/10.3322/canjclin.41.4.201
|
[3]
|
Le Douarin, N.M. (1986) Cell Line Segregation during Peripheral Nervous System Ontogeny. Science, 231, 1515-1522.
http://dx.doi.org/10.1126/science.3952494
|
[4]
|
Erickson, C.A. (1993) From the Crest to the Periphery: Control of Pigment Cell Migration and Segregation. Pigment Cell Research, 6, 336-347. http://dx.doi.org/10.1111/j.1600-0749.1993.tb00611.x
|
[5]
|
Shivers, S.C., Wang, X., Li, W., et al. (1998) Molecular Staging of Malignant Melanoma: Correlation with Clinical Outcome. JAMA, 280, 1410-1415. http://dx.doi.org/10.1001/jama.280.16.1410
|
[6]
|
Kobayashi, N., Nakagawa, A., Muramatsu, T., et al. (1998) Supranuclear Melanin Caps Reduce Ultraviolet Induced DNA Photoproducts in Human Epidermis. Journal of Investigative Dermatology, 110, 806-810.
http://dx.doi.org/10.1046/j.1523-1747.1998.00178.x
|
[7]
|
Gilchrest, B.A., Eller, M.S., Geller, A.C., et al. (1999) The Pathogenesis of Melanoma Induced by Ultraviolet Radiation. The New England Journal of Medicine, 340, 1341-1348. http://dx.doi.org/10.1056/NEJM199904293401707
|
[8]
|
Plettenberg, A. (1995) Human Melanocytes and Melanoma Cells Constitutively Express the Bcl-Photo-Onocogene in Situ and in Cell Culture. American Journal of Pathology, 146, 651-659.
|
[9]
|
Dubertret, L. (1998) Daily Photo Protection. 7th Congress of the European Academy of Dermatology and Venereology, Nice.
|
[10]
|
McKay, B.C., Francis, M.A. and Rainbow, A.J. (1997) Wildtype p53 Is Required for Heat Shock and Ultraviolet Light Enhanced Repair of a UV-Damaged Reporter Gene. Carcinogenesis, 18, 245-249.
http://dx.doi.org/10.1093/carcin/18.2.245
|
[11]
|
Le, X.C., Xing, J.Z., Lee, J., et al. (1998) Inducible Repair of Thymine Glycol Detected by an Ultra Sensitive Assay for DNA Damage. Science, 280, 1066-1069. http://dx.doi.org/10.1126/science.280.5366.1066
|
[12]
|
Eller, M.S., Maeda, T., Magnoni, C., et al. (1997) Enhancement of DNA Repair in Human Skin Cells by Thymidine Nucleotides: Evidence for a p53 Mediated Mammalian SOS Response. Proceedings of the National Academy of Sciences of the United States of America, 94, 12627-12632. http://dx.doi.org/10.1073/pnas.94.23.12627
|
[13]
|
Longstreth, J.D. (1995) Effects of Increased Solar Radiation on Human Health. Ambio, 24, 153.
|
[14]
|
Bataille, V., Bishop, J.A., Sasieni, P., et al. (1996) Risk of Cutaneous Melanoma in Relation to the Numbers, Types and Sites of Naevi: A Case-Control Study. British Journal of Cancer, 73, 1605-1611.
http://dx.doi.org/10.1038/bjc.1996.302
|
[15]
|
Marghoob, A.A. (1999) The Dangers of Atypical Mole (Dysplastic Nevus) Syndrome. Teaching At-Risk Patients to Protect Themselves from Melanoma. Postgraduate Medicine, 105, 147-148, 151-152, 154.
|
[16]
|
Snels, D.G., Hille, E.T., Gruis, N.A. and Bergman, W. (1999) Risk of Cutaneous Malignant Melanoma in Patients with Nonfamilial Atypical Nevi from a Pigmented Lesions Clinic. Journal of the American Academy of Dermatology, 40, 686-693. http://dx.doi.org/10.1016/S0190-9622(99)70564-5
|
[17]
|
Sauder, D.N. (1999) The Etiology of Malignant Melanoma. Journal of Cutaneous Medicine and Surgery, 3, 287.
|
[18]
|
Clemente, C., Cochran, A.J., Elder, D.E., Levene, A., Mackie, R.M., Mihm, M.C., et al. (1991) Histopathologic Diagnosis of Dysplastic Nevi: Concordance among Pathologists Convened by the World Health Organization Melanoma Programme. Human Pathology, 22, 313-319. http://dx.doi.org/10.1016/0046-8177(91)90078-4
|
[19]
|
Skender-Kalmenas, T.M., English, D.R. and Heenan, P.J. (1995) Benign Melanocytic Lesions: Risk Markers of Precursors of Cutaneous Melanoma? Journal of the American Academy of Dermatology, 33, 1000-1007.
http://dx.doi.org/10.1016/0190-9622(95)90294-5
|
[20]
|
Rigel, D.S. (1992) Epidemiology and Prognostic Factors in Malignant Melanoma. Annals of Plastic Surgery, 28, 7-8.
http://dx.doi.org/10.1097/00000637-199201000-00003
|
[21]
|
Armstrong, B.K. and English, D.R. (1992) Epidemiologic Studies. In: Balch, C.M., Milton, G.W. and Soong, S.J., Eds., Cutaneous Melanoma, JB Lippinncott, Philadelphia.
|
[22]
|
Mancianti, M.L., Herlyn, M., Weil, D., Jambrosic, J., Rodeck, U., Becker, D., et al. (1988) Growth and Phenotypic Characteristics of Human Nevus Cells in Culture. Journal of Investigative Dermatology, 90, 134-141.
http://dx.doi.org/10.1111/1523-1747.ep12462099
|
[23]
|
Westermark, B., Johnsson, A., Paulsson, Y., Betsholtz, C., Heldin, C.H., Herlyn, M., et al. (1986) Human Melanoma Cell Lines of Primary and Metastatic Origin Express the Genes Encoding the Chains of Platelet-Derived Growth Factor PDGF and Produce a PDGF-Like Growth Factor. Proceedings of the National Academy of Sciences of the United States of America, 83, 7197-7200. http://dx.doi.org/10.1073/pnas.83.19.7197
|
[24]
|
Bizik, J., Felnerova, D., Grofova, M. and Vaheri, A. (1996) Active Transforming Growth Factor-Beta in Human Melanoma Cell Lines: No Evidence for Plasmin-Related Activation of Latent TGF-Beta. Journal of Cellular Biochemistry, 62, 113-122.
|
[25]
|
Reed, J.A., McNutt, N.S., Prieto, V.G. and Albino, A.P. (1994) Expression of Transforming Growth Factor Beta 2 in Malignant Melanoma Correlates with the Depth of Tumor Invasion. Implications for Tumor Progression. American Journal of Pathology, 145, 97-104.
|
[26]
|
Bennicelli, J.L., Elias, J., Kern, J. and Guerry, D. (1989) Production of Interleukin 1 Activity by Cultured Human Melanoma Cells. Cancer Research, 49, 930-935.
|
[27]
|
Scheibenbogen, C., Möhler, T., Haefele, J., Hunstein, W. and Keilholz, U. (1995) Serum Interleukin-8 (IL-8) as Elevated in Patients with Metastatic Melanoma and Correlates with Tumor Load. Melanoma Research, 5, 179.
http://dx.doi.org/10.1097/00008390-199506000-00006
|
[28]
|
Dummer, W., Becker, J.C., Schwaaf, A., Leverkus, M., Moll, T. and Bröcker, E.B. (1995) Elevated Serum Levels of Interleukin-10 in Patients with Metastatic Malignant Melanoma. Melanona Research, 5, 67.
http://dx.doi.org/10.1097/00008390-199502000-00008
|
[29]
|
Thompson, F.H., Emerson, J., Olson, S., Weinstein, R., Leavitt, S.A., Leong, S.P.L., et al. (1995) Cytogenetics of 158 Patients with Regional or Disseminated Melanoma Subset Analysis of Near-Diploid and Simple Karyotypes. Cancer Genetics and Cytogenetics, 83, 93-104. http://dx.doi.org/10.1016/0165-4608(95)00057-V
|
[30]
|
Glendening, J.M., Flores, J.F., Walker, G.J., Stone, S., Albino, A.P. and Fountain, J.W. (1995) Homozygous Loss of the p15INK4B Gene (and Not the p16INK4 Gene) during tumor Progression in a Sporadic Melanoma Patient. Cancer Research, 55, 5531-5535.
|
[31]
|
Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., et al. (1994) A Cell Cycle Regulator Potentially Involved in the Genesis of Many Tumor Types. Science, 364, 436-440.
http://dx.doi.org/10.1126/science.8153634
|
[32]
|
Monzon, J., Liu, L., Brill, H., Goldstein, A.M., Tucker, M.A., From, L., et al. (1998) CDKN2A Mutations in Multiple Primary Melanomas. The New England Journal of Medicine, 338, 879-887.
http://dx.doi.org/10.1056/NEJM199803263381305
|